Vision Loss News and Research

RSS

Macular degeneration patients benefit from self-management training

A 12-hour self-management program for individuals with advanced age-related macular degeneration (AMD) leads to lasting improvements in mood and function, especially in depressed patients, and decreases the development of clinical depression in AMD patients over time, according to a University of California, San Diego (UCSD) Shiley Eye Center study published in the January 2005 Archives of Ophthalmology.

10 Jan 2005

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Results from two concurrent, prospective, double-blind, multi-center clinical trials show that pegaptanib (Macugen), an anti-vascular endothelial growth factor therapy, is an effective treatment for neovascular age-related macular degeneration (AMD), according to a paper in the Dec. 30 issue of the New England Journal of Medicine. Macugen was approved by the Food and Drug Administration on Dec. 17.

30 Dec 2004

Drivers with epilepsy are on the road again

As a result of a worldwide cooperative movement, the absolute driving ban for people with epilepsy (PWE) has been lifted in Japan. Since 1960, people who have epilepsy have been banned from driving in Japan.

22 Dec 2004

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Eyetech Pharmaceuticals and Pfizer have announced that the U.S. Food and Drug Administration (FDA) approved Macugen (pegaptanib sodium injection) for the treatment of neovascular (wet) age-related macular degeneration (AMD), an eye disease associated with aging that destroys central vision.

20 Dec 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Discovery of a new blindness gene

The discovery by a Leeds University scientist of a new blindness gene could help to save the sight of thousands of sufferers of retinal disease which affects premature babies as well as people over 60.

4 Nov 2004

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Academy of Ophthalmology reacts to recent study on eye exams for children

Sean Donahue, M.D., Ph.D., a pediatric ophthalmologist at Vanderbilt Medical Center in Nashville Tenn., agrees. "The data used in this paper unfortunately mixes well-conducted clinical trials and weak, poorly conducted and non-controlled studies."

29 Sep 2004

Significance of central corneal thickness on the management of glaucoma

In a new study, researchers at Columbia University Medical Center demonstrated the significance of central corneal thickness (CCT) on the clinical management of patients with glaucoma and those suspected to have glaucoma.

23 Sep 2004

Children with complications from acute sinusits may experience significant illness from their infection

Acute sinusitis is a common pediatric disorder, accounting for 21 percent of children’s antibiotic prescriptions.

17 Sep 2004

Strep A is showing up in increased numbers of head and neck abscesses

Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.

17 Sep 2004

Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations

A team of researchers from The Scripps Research Institute was able to preserve visual function in mice that were genetically predisposed to developing a profound degenerative disease that destroys their retinas.

16 Sep 2004

New glaucoma risk assessment principles help physicians decide who needs treatment

A new approach for assessing glaucoma risk factors could be the first step in helping ophthalmologists determine the risk of progression from ocular hypertension to glaucoma and blindness, according to an article published today in the September issue of the American Journal of Ophthalmology.

14 Sep 2004

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

12 Sep 2004

Vision Loss News and Research

Macular degeneration patients benefit from self-management training

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Drivers with epilepsy are on the road again

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Discovery of a new blindness gene

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Academy of Ophthalmology reacts to recent study on eye exams for children

Significance of central corneal thickness on the management of glaucoma

Children with complications from acute sinusits may experience significant illness from their infection

Strep A is showing up in increased numbers of head and neck abscesses

Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations

New glaucoma risk assessment principles help physicians decide who needs treatment

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Treatment with vitamin A and an omega-3 fatty acid slows down the progression of retinitis pigmentosa

Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes

Pineal gland which regulates the cycles of sleep and waking evolved to improve vision

Latinos living in the United States have high rates of eye disease and visual impairment

Smart drug that targets cancer cells in the brain following removal of a tumor

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News